Mengyi Du

636 total citations
28 papers, 390 citations indexed

About

Mengyi Du is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Mengyi Du has authored 28 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Mengyi Du's work include CAR-T cell therapy research (16 papers), Acute Myeloid Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Mengyi Du is often cited by papers focused on CAR-T cell therapy research (16 papers), Acute Myeloid Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Mengyi Du collaborates with scholars based in China, Netherlands and United States. Mengyi Du's co-authors include Heng Mei, Yu Hu, Huiwen Jiang, Chenggong Li, Jianghua Wu, Lu Tang, Cees J.N. Buisman, Min Xu, Yinqiang Zhang and Wenjing Luo and has published in prestigious journals such as Blood, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Mengyi Du

25 papers receiving 387 citations

Peers

Mengyi Du
Yishan Ye China
Seiko Iwata Japan
Mariangela Scavone Italy
Shinichiro Suzuki Japan
Xuan Han China
Fen Fu China
Azadeh Omidkhoda Iran
Lea Miebach Germany
Debra Ellis United States
Siting Zheng China
Yishan Ye China
Mengyi Du
Citations per year, relative to Mengyi Du Mengyi Du (= 1×) peers Yishan Ye

Countries citing papers authored by Mengyi Du

Since Specialization
Citations

This map shows the geographic impact of Mengyi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyi Du more than expected).

Fields of papers citing papers by Mengyi Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengyi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyi Du. The network helps show where Mengyi Du may publish in the future.

Co-authorship network of co-authors of Mengyi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Mengyi Du. A scholar is included among the top collaborators of Mengyi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengyi Du. Mengyi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Yingying, Zhong Wu, Huiwen Jiang, et al.. (2024). IL-1β Induce CAR-T-Associated Coagulopathy Via the Hsp90/Kallikrein/uPA Pathway. Blood. 144(Supplement 1). 1197–1197. 1 indexed citations
4.
5.
Du, Mengyi, et al.. (2023). [Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia].. PubMed. 44(10). 793–799. 3 indexed citations
6.
Zhang, Yinqiang, Chenggong Li, Mengyi Du, et al.. (2023). Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer Journal. 13(1). 61–61. 52 indexed citations
7.
Luo, Wenjing, Chenggong Li, Yinqiang Zhang, et al.. (2022). Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis. BMC Cancer. 22(1). 98–98. 35 indexed citations
8.
Du, Mengyi, Linlin Huang, Haiming Kou, et al.. (2022). Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma. Frontiers in Immunology. 13. 898341–898341. 6 indexed citations
9.
Xu, Min, Mengyi Du, Lu Tang, et al.. (2022). Simvastatin Improves Outcomes of Endotoxin-induced Coagulopathy by Regulating Intestinal Microenvironment. Current Medical Science. 42(1). 26–38. 9 indexed citations
10.
Zhang, Yinqiang, Fen Zhou, Yingnan Li, et al.. (2022). Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia. Frontiers in Immunology. 13. 914959–914959. 16 indexed citations
11.
Du, Mengyi, Heng Mei, Chenggong Li, et al.. (2021). Single-Cell Analyses Identify Transcriptional Characterizations of Subsets Associated with Efficacy and Toxicity for CAR-T Immunotherapy in B-ALL Patients. Blood. 138(Supplement 1). 4815–4815. 1 indexed citations
12.
Luo, Lili, Ting Luo, Mengyi Du, Heng Mei, & Yu‐Feng Hu. (2021). Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis. Journal of Infection. 84(3). 418–467. 5 indexed citations
13.
Tang, Lu, Jianghua Wu, Huiwen Jiang, et al.. (2020). Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia. Clinical Cancer Research. 26(7). 1763–1772. 88 indexed citations
14.
Luo, Lili, Min Xu, Mengyi Du, et al.. (2020). Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging. 12(16). 15918–15937. 17 indexed citations
15.
Wang, Jing, Wei Shi, Bo Zhang, et al.. (2019). Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. Acta Biomaterialia. 90. 324–336. 24 indexed citations
16.
Zhou, Fan, Fen Zhou, Mengyi Du, et al.. (2019). Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients. International Journal of Hematology. 110(5). 575–583. 3 indexed citations
17.
Du, Mengyi, Fen Zhou, Runming Jin, Yu Hu, & Heng Mei. (2019). Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis. Leukemia Research. 80. 11–18. 12 indexed citations
18.
Lei, Yang, Mengyi Du, Philipp Kuntke, et al.. (2019). Energy Efficient Phosphorus Recovery by Microbial Electrolysis Cell Induced Calcium Phosphate Precipitation. ACS Sustainable Chemistry & Engineering. 7(9). 8860–8867. 57 indexed citations
19.
Du, Mengyi, Min Xu, Jun Deng, et al.. (2019). Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population. Journal of Cancer. 11(2). 508–519. 8 indexed citations
20.
Ren, Xiang, Na Wang, Chenghong Zhang, et al.. (2017). Thioredoxin is implicated in the anti-apoptotic effects of grape seed proanthocyanidin extract during hyperglycemia. Molecular Medicine Reports. 16(5). 7731–7737. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yishan Ye Breakdown of academic impact, for papers by Seiko Iwata Breakdown of academic impact, for papers by Mariangela Scavone Breakdown of academic impact, for papers by Shinichiro Suzuki Breakdown of academic impact, for papers by Xuan Han Breakdown of academic impact, for papers by Fen Fu Breakdown of academic impact, for papers by Azadeh Omidkhoda Breakdown of academic impact, for papers by Lea Miebach Breakdown of academic impact, for papers by Debra Ellis Breakdown of academic impact, for papers by Siting Zheng
Rankless by CCL
2026